Search Results - "Chirovsky D"

Abstract: P1262 PREVALENCE OF MIXED DYSLIPIDEMIA IN AUSTRALIAN PATIENTS ON LIPID MODIFYING THERAPY

Authors: Colquhoun, D Chirovsky, D Ambegaonkar, B et al.

Source: Atherosclerosis (Supplements). Jun2009, Vol. 10 Issue 2, pe1318-e1318. 1p.

PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France.

Authors: Massetti, M. Even, C. Geoffrois, L. et al.

Source: Value in Health. 2020 Supplement 2, Vol. 23, pS436-S436. 1p.

271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan.

Authors: Wang, C.H. Lei, H.L. Borse, R. et al.

Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1349-S1349. 1p.

1082PProgrammed death-ligand 1 (PD-L1) expression and HPV-associated p16 in oropharyngeal squamous cell carcinoma (OSCC) treated with primary curative radiotherapy (RT).

Authors: Steiniche, T Eriksen, J G Lilja-Fischer, J K et al.

Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Erratum to: Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005-2008: is treatment with bisphosphonates an option?

Authors: Lubwama, R. Nguyen, A. Modi, A. et al.

Source: Osteoporosis International. Dec2014, Vol. 25 Issue 12, p2841-2841. 1p.

URL: 99256349

RESOURCE UTILIZATION AMONG PATIENTS WITH METABOLIC SYNDROME: ISOLATED VS. MULTIPLE LIPID DISORDERS

Authors: Ambegaonkar, B.M. Rothwell-Hesketh, A. Milligan, G. et al.

Source: Atherosclerosis (Supplements). May2008, Vol. 9 Issue 1, p126-126. 1p.

5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC.

Authors: Velcheti V Rai P Kao YH et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2024 Sep; Vol. 25 (6), pp. 502-508.e3. Date of Electronic Publication: 2024 May 16.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection.

Authors: Hu X Chirovsky D Walker MS et al.

Source: BMC pulmonary medicine [BMC Pulm Med] 2024 Jul 10; Vol. 24 (1), pp. 332. Date of Electronic Publication: 2024 Jul 10.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE

Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer.

Authors: Donington J Hu X Zhang S et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2024 Jul; Vol. 25 (5), pp. 440-448. Date of Electronic Publication: 2024 Mar 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

Authors: Liu SV Babel RA Kao YH et al.

Source: Immunotherapy [Immunotherapy] 2025 Oct; Vol. 17 (14), pp. 1005-1013. Date of Electronic Publication: 2025 Oct 17.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-7448 (Electronic) Linking ISSN: 1750743X NLM ISO Abbreviation: Immunotherapy Subsets: MEDLINE

Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.

Authors: Herbst RS Cho BC Zhou C et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Sep; Vol. 20 (9), pp. 1302-1314. Date of Electronic Publication: 2025 May 24.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy.

Authors: Wagenius G Vikström A Berglund A et al.

Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Apr 21; Vol. 63, pp. 198-205. Date of Electronic Publication: 2024 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors.

Authors: Halmos B Rai P Min J et al.

Source: Frontiers in oncology [Front Oncol] 2024 Apr 18; Vol. 14, pp. 1285280. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data.

Authors: West H Hu X Zhang S et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2023 May; Vol. 24 (3), pp. 260-268. Date of Electronic Publication: 2022 Dec 25.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.

Authors: Wagenius G Vikström A Berglund A et al.

Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2025 Mar 17; Vol. 64, pp. 415-422. Date of Electronic Publication: 2025 Mar 17.

Publication Type: Journal Article

Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

Authors: Yang JC Lee DH Lee JS et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec; Vol. 42 (34), pp. 4029-4039. Date of Electronic Publication: 2024 Aug 22.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma.

Authors: Hong MH Park S Vo T et al.

Source: ESMO open [ESMO Open] 2024 Nov; Vol. 9 (11), pp. 103961. Date of Electronic Publication: 2024 Oct 25.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis.

Authors: Black CM Keeping S Mojebi A et al.

Source: Frontiers in oncology [Front Oncol] 2022 Apr 28; Vol. 12, pp. 868490. Date of Electronic Publication: 2022 Apr 28 (Print Publication: 2022).

Publication Type: Systematic Review; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States.

Authors: Borse RH Ramakrishnan K Gandhi J et al.

Source: Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 954-965.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy.

Authors: Donington J Hu X Zhang S et al.

Source: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2024 Oct; Vol. 168 (4), pp. 1261-1269.e1. Date of Electronic Publication: 2023 Dec 12.

Publication Type: Journal Article

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X (Electronic) Linking ISSN: 00225223 NLM ISO Abbreviation: J Thorac Cardiovasc Surg Subsets: MEDLINE